Novavax Inc (NVAX)

EBITDA Margin

-49.68%

TTM · Period ending:

NVAX logo

NVAX EBITDA Margin

Latest reported-49.68%
NVAX TTM EBITDA Margin (-1600.00% → -49.68%)
High-resolution chart · PNG

NVAX ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Novavax Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-49.6841%
-7.0639%
43.8216%
38.5099%
45.9406%
44.2161%
-15.8385%
-24.4416%
-27.7427%
-40.5269%
-66.6376%
-68.4564%
-37.1159%
-91.6704%
-33.3543%
-156.8291%
-578.7087%
-352.1289%
-850.6628%
-85.6542%
-77.4818%
-64.0473%
-83.6574%
-124.4907%
-153.2645%
-543.4679%
-613.4069%
-817.4545%
-735.5219%
-560.2928%
-475.3179%
-425.7564%
-415.0523%
-462.3745%
-512.8304%
-634.7284%
-898.3367%
-1,335.3078%
-1,688.074%
-1,813.6838%
-1,348.9922%
-661.6207%
-420.8436%
-283.7185%
-238.2289%
-272.622%
-262.6798%
-189.5144%
-197.6666%
-217.4143%
-236.564%
-271.0555%
-212.7211%
-144.8911%
-128.3566%
-97.0927%
-87.5962%
-109.2398%
-137.7791%
-240.5105%
-675.2278%
-2,813.3083%
-9,945.7726%
-11,894.2623%
-10,586.7347%
-9,783.5749%
-11,135.0769%
-9,728.3489%
-10,504.1401%
-5,310.8453%
-3,145.3947%
-7,634.2466%
-1,820.4576%
-2,136.1751%
-1,894.246%
-908.3978%
-836.8577%
-635.1779%
-467.4781%
-150.5108%
-68.2872%
-30.0815%
-77.098%
-304.0473%
-369.9799%
-368.3318%
-239.926%
-138.5686%
-111.931%
-101.3177%
-126.1412%
-177.2809%
-267.4525%
-210.8362%
-142.3725%
-97.2507%
-63.9402%
-38.009%
-23.9591%
-44.935%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.